(Total Views: 506)
Posted On: 02/24/2020 7:14:38 AM
Post# of 155785
Eli Lilly (NYSE:LLY) has completed its acquisition of 26,043,820 common shares of Loxo Oncology (NASDAQ:LOXO) at $235 per share for a total of ~$6.12B, representing an 84.6% stake.
_______________________
Or about $14 per share of CYDY (430 mil/26mil)
_______________________
Or about $14 per share of CYDY (430 mil/26mil)


Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.